Clene CMO retiring Apr 1; Dr. Benjamin Greenberg named Head of Medical

Clene Inc.

Robert Glanzman, M.D., Chief Medical Officer, retiring effective April 1, 2023; will provide consulting services at $300/hour for one year.
Stock options granted pre-retirement continue vesting during the one-year consulting term; unvested options expire per 2020 Stock Plan.
Benjamin Greenberg, M.D., M.H.S., appointed Head of Medical effective April 1, 2023; continues as neurology professor at UT Southwestern.

item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robert Glanzman

Chief Medical Officer

CLNN · Clene Inc.

Effective: 2023-04-01
Filed: March 17, 2023, 7:59 PM ET

On March 15, 2023, Robert Glanzman, M.D., FAAN, the Chief Medical Officer of Clene Inc. (the “Company”), notified the Company of his intent to retire from his position, effective as of April 1, 2023 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Glanzman retired as Chief Medical Officer at Clene Inc..

Action: retired
Role: Chief Medical Officer

Exact text from the filing

On March 15, 2023, Robert Glanzman, M.D., FAAN, the Chief Medical Officer of Clene Inc. (the “Company”), notified the Company of his intent to retire from his position, effective as of April 1, 2023 (the “Effective Date”).

View on SEC.gov

Clene Inc. filing history →

Source: SEC EDGAR

accession 0001437749-23-007054

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.